1. Home
  2. WAY vs LNTH Comparison

WAY vs LNTH Comparison

Compare WAY & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAY
  • LNTH
  • Stock Information
  • Founded
  • WAY 1999
  • LNTH 1956
  • Country
  • WAY United States
  • LNTH United States
  • Employees
  • WAY N/A
  • LNTH N/A
  • Industry
  • WAY
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • WAY
  • LNTH Health Care
  • Exchange
  • WAY Nasdaq
  • LNTH Nasdaq
  • Market Cap
  • WAY 6.8B
  • LNTH 7.5B
  • IPO Year
  • WAY 2024
  • LNTH 2015
  • Fundamental
  • Price
  • WAY $39.98
  • LNTH $75.56
  • Analyst Decision
  • WAY Strong Buy
  • LNTH Strong Buy
  • Analyst Count
  • WAY 12
  • LNTH 5
  • Target Price
  • WAY $41.45
  • LNTH $133.80
  • AVG Volume (30 Days)
  • WAY 2.0M
  • LNTH 1.5M
  • Earning Date
  • WAY 04-30-2025
  • LNTH 05-07-2025
  • Dividend Yield
  • WAY N/A
  • LNTH N/A
  • EPS Growth
  • WAY N/A
  • LNTH N/A
  • EPS
  • WAY 0.15
  • LNTH 3.53
  • Revenue
  • WAY $975,192,000.00
  • LNTH $1,536,699,000.00
  • Revenue This Year
  • WAY $8.84
  • LNTH $4.63
  • Revenue Next Year
  • WAY $9.35
  • LNTH $9.35
  • P/E Ratio
  • WAY $260.84
  • LNTH $21.40
  • Revenue Growth
  • WAY 18.25
  • LNTH 12.53
  • 52 Week Low
  • WAY $20.26
  • LNTH $73.11
  • 52 Week High
  • WAY $48.11
  • LNTH $126.89
  • Technical
  • Relative Strength Index (RSI)
  • WAY N/A
  • LNTH 32.65
  • Support Level
  • WAY N/A
  • LNTH $73.75
  • Resistance Level
  • WAY N/A
  • LNTH $76.34
  • Average True Range (ATR)
  • WAY 0.00
  • LNTH 2.50
  • MACD
  • WAY 0.00
  • LNTH -0.09
  • Stochastic Oscillator
  • WAY 0.00
  • LNTH 23.36

About WAY Waystar Holding Corp. Common Stock

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: